NCT07377643 IBI354 With or Without Pertuzumab Versus Taxane, Trastuzumab and Pertuzumab in HER2-positive Metastatic Breast Cancer Status RECRUITING Phase PHASE3
NCT06834672 Study of IBI354 Versus Investigator's Choice of Chemotherapy in Patients With Platinum-resistant Ovarian, Primary Peritoneal, or Fallopian Tube Cancer Status RECRUITING Phase PHASE3
NCT05636215 A First-in-human Study of IBI354 in Subjects with Locally Advanced Unresectable or Metastatic Solid Tumors Status RECRUITING Phase PHASE1/PHASE2